Skip to main content

Table 2 Univariate and multivariate analysis for overall survival of glioma patients

From: Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

Variable Univariate analysis Multivariate analysis
Age HR 95 % CI pvalue HR 95 % CI pvalue
 (≥ 40 vs. < 40) 1.6 (1.4-2.0) < 0.001 1.26 (1.04 − 1.52) 0.017
Gender       
 Female vs. male 0.98 (0.83–1.2) 0.79    
Grade       
 II vs. III vs. IV 3.6 (2.2–6.2) < 0.001 2.75 (2.06 − 3.68) < 0.001
Recurrence       
 Primary vs. Recurrent vs. Secondary 2.5 (1.8–3.2) < 0.001 2.17 (1.81 − 2.62) < 0.001
IDH status       
 Wildtype vs. Mutant 3.1 (2.6–3.6) < 0.001 2.46 (1.97–3.01) < 0.001
Radio status       
 Yes vs. no 1 (0.83–1.3) 0.73    
Chemo status       
 Yes vs. no 1.5 (1.3–1.9) < 0.001 1.4 (1.2–1.8) < 0.001
FCER1G       
 Low vs. High 0.43 (0.36–0.51) < 0.001 0.66 (0.54 − 0.79) < 0.001